Bio-Key International Files Annual Proxy Statement
Ticker: BKYI · Form: DEF 14A · Filed: Jul 10, 2024 · CIK: 1019034
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance, executive-compensation
Related Tickers: BKII
TL;DR
BIO-KEY files proxy statement for Aug 22 meeting - shareholders vote on exec pay & board.
AI Summary
Bio-Key International Inc. filed its DEF 14A on July 10, 2024, for the fiscal year ending December 31, 2023. The filing pertains to the company's annual meeting of stockholders, which is scheduled for August 22, 2024. This document provides details on executive compensation, board nominations, and other corporate governance matters.
Why It Matters
This filing is crucial for shareholders as it outlines the company's governance, executive pay, and voting matters ahead of the annual meeting.
Risk Assessment
Risk Level: medium — DEF 14A filings are routine disclosures, but the specific details within can reveal potential governance or compensation-related risks.
Key Numbers
- 2023 — Fiscal Year End (The filing covers the company's performance and governance for this period.)
- 20240822 — Annual Meeting Date (Shareholders will vote on proposals at this meeting.)
Key Players & Entities
- BIO KEY INTERNATIONAL INC (company) — Filer
- 0001437749-24-022480 (filing_id) — Accession Number
- 20240710 (date) — Filing Date
- 20240822 (date) — Annual Meeting Date
- 101 CRAWFORDS CORNER RD SUITE 4116 (address) — Company Business Address
- HOLMDEL, NJ 07733 (address) — Company Business Address
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information regarding the company's annual meeting of stockholders, including details on executive compensation, board nominations, and voting matters.
When is the annual meeting of stockholders scheduled to take place?
The annual meeting of stockholders is scheduled for August 22, 2024.
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
What is the filing date of this DEF 14A?
This DEF 14A filing was made on July 10, 2024.
What is the company's business address?
The company's business address is 101 CRAWFORDS CORNER RD, SUITE 4116, HOLMDEL, NJ 07733.
Filing Stats: 4,777 words · 19 min read · ~16 pages · Grade level 12.5 · Accepted 2024-07-10 16:30:50
Filing Documents
- bkyi20240705_def14a.htm (DEF 14A) — 453KB
- depasqualesig.jpg (GRAPHIC) — 4KB
- logo.jpg (GRAPHIC) — 7KB
- proxy01.jpg (GRAPHIC) — 254KB
- proxy02.jpg (GRAPHIC) — 137KB
- 0001437749-24-022480.txt ( ) — 2033KB
- bkyi-20231231.xsd (EX-101.SCH) — 3KB
- bkyi-20231231_def.xml (EX-101.DEF) — 2KB
- bkyi-20231231_lab.xml (EX-101.LAB) — 2KB
- bkyi-20231231_pre.xml (EX-101.PRE) — 1KB
- bkyi20240705_def14a_htm.xml (XML) — 130KB
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION 12 DIRECTOR COMPENSATION 20 PROPOSAL 2: RATIFICATION OF THE SELECTION OF BUSH & ASSOCIATES CPA LLC AS THE COMPANY ' S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2024 21 REPORT OF THE AUDIT COMMITTEE 22 PROPOSAL 3: ADVISORY VOTE ON EXECUTIVE COMPENSATION 23 PROPOSAL 4: ADVISORY VOTE ON FREQUENCY OF THE ADVISORY APPROVAL OF OUR EXECUTIVE COMPENSATION 24 DELINQUENT SECTION 16(a) REPORTS 24 STOCKHOLDER PROPOSALS 25 STOCKHOLDER COMMUNICATIONS 26 OTHER MATTERS 26 ANNUAL REPORT ON FORM 10-K 26 WHERE YOU CAN FIND MORE INFORMATION 26 i BIO-key International, Inc. 101 Crawfords Corner Road, Suite 4116 Holmdel, NJ 07733 PROXY STATEMENT 2024 ANNUAL MEETING OF STOCKHOLDERS The enclosed proxy is solicited by the board of directors of BIO-key International, Inc. (the "Company," "we" or "us") for use at the 2024 Annual Meeting of Stockholders (the "Annual Meeting") to be held on Thursday, August 22, 2024, at 10:00 a.m., local time, at our offices at 101 Crawfords Corner Road, Suite 4116, Holmdel, NJ 07733, and at any continuation, adjournment or postponement thereof. GENERAL INFORMATION ABOUT THE ANNUAL MEETING AND VOTING Who Can Attend and Vote Only holders of our common stock of record at the close of business on July 1, 2024, the record date, are entitled to notice of and to vote at the Annual Meeting, and at any continuation(s), postponement(s) or adjournment(s) thereof. As of the record date, 1,814,228 shares of our common stock, par value $.0001 per share ("common stock"), were issued and outstanding. Holders of our common stock are entitled to one vote per share for each proposal presented at the Annual Meeting. The common stock does not have cumulative voting rights. Voting Your Shares If you are a registered holder, meaning that you hold our stock directly (not through a bank, broker or other nominee), you may vote in person at the Annual Meeting or by completi